In Honduras, the pregnant women living with hiv antiretroviral therapy coverage for pmtct currently stands at 41%, reflecting an increase of 1% (2.5%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Honduras
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Honduras
PMTCT antiretroviral therapy coverage
More indicators for Honduras
Male unintentional poisoning
0.8
0.0
(2019)
Female wasting in children
1.8%
+0.9%
(2019)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar290
+intl dollar50
(2021)
Birth registration
97%
+3.4%
(2019)
Contraceptive modern method prevalence
66.5%
+2.7%
(2019)
Honduras PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 41% | +1% |
| 2021 | 40% | +4% |
| 2020 | 36% | -5% |
| 2019 | 41% | -9% |
| 2018 | 50% | +8% |
| 2017 | 42% | +4% |
| 2016 | 38% | +2% |
| 2015 | 36% | -3% |
| 2014 | 39% | +2% |
| 2013 | 37% | -2% |
| 2012 | 39% | +4% |
| 2011 | 35% | +2% |
| 2010 | 33% | -3% |
| 2009 | 36% | +16% |
| 2008 | 20% | +1% |
| 2007 | 19% | +5% |
| 2006 | 14% | +5% |
| 2005 | 9% | +4% |
| 2004 | 5% | +3% |
| 2003 | 2% | +2% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |